Cargando…

Age, pathology and CA-125 are prognostic factors for survival in patients with brain metastases from gynaecological tumours

BACKGROUND AND PURPOSE: Brain metastases originating from gynaecological tumours are a rare phenomenon, but have an increasing incidence due to better targeted therapies. This study aimed to identify factors that predict survival in these patients, which can be used in creating a robust prognostic t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagtegaal, S.H.J., Hulsbergen, A.F.C., van Dorst, E.B.L., Kavouridis, V.K., Jessurun, C.A.C., Broekman, M.L.D., Smith, T.R., Verhoeff, J.J.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306503/ https://www.ncbi.nlm.nih.gov/pubmed/32596517 http://dx.doi.org/10.1016/j.ctro.2020.05.001

Ejemplares similares

75. PROGRAMMED DEATH RECEPTOR LIGAND ONE EXPRESSION MAY INDEPENDENTLY PREDICT SURVIVAL IN NON-SMALL CELL LUNG CARCINOMA BRAIN METASTASES PATIENTS RECEIVING IMMUNOTHERAPY
por: Hulsbergen, Alexander, et al.
Publicado: (2020)

Subtype switching in breast cancer brain metastases: a multicenter analysis
por: Hulsbergen, Alexander F C, et al.
Publicado: (2020)

Morphological changes after cranial fractionated photon radiotherapy: Localized loss of white matter and grey matter volume with increasing dose
por: Nagtegaal, S.H.J., et al.
Publicado: (2021)

Leptomeningeal disease in neurosurgical brain metastases patients: A systematic review and meta-analysis
por: Tewarie, Ishaan Ashwini, et al.
Publicado: (2021)

72. THE COMBINED USE OF STEROIDS AND IMMUNE CHECKPOINT INHIBITORS IN BRAIN METASTASES PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Jessurun, Charissa, et al.
Publicado: (2020)

67. INCREASED RISK OF BREAST CANCER BRAIN METASTASIS WITH EGFR AND Ki-67 EXPRESSION: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Job, Arun, et al.
Publicado: (2020)

Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?
por: Jessurun, Charissa A. C., et al.
Publicado: (2019)

CA125 effects on humoral immunosuppression
por: Kline, J. Bradford, et al.
Publicado: (2017)

Is an increase in CA 125 in breast cancer patients an indicator of pleural metastases?
por: Jäger, W., et al.
Publicado: (1994)

74. EFFICACY OF HER2-TARGETED THERAPY IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES: A NATIONAL ANALYSIS
por: Hulsbergen, Alexander, et al.
Publicado: (2020)

Obstetrics and Gynæcology
por: Kynoch, J. A. C.
Publicado: (1907)

OTHR-04. INCIDENCE AND SURVIVAL OUTCOMES IN UROTHELIAL CARCINOMA BRAIN METASTASES
por: Kavouridis, Vasileios, et al.
Publicado: (2019)

Ischemic stroke after radiation therapy for pituitary adenomas: a systematic review
por: van Westrhenen, A., et al.
Publicado: (2017)

The Practitioner's Manual of Gynæcology
por: Leicester, J. C. H.
Publicado: (1922)

Peritoneal trauma releases CA125?
por: Redman, C. W., et al.
Publicado: (1988)

SDPS-26 UNINTENDED RADIOTHERAPY DOSE ON THE NEUROGENIC NICHES IS ASSOCIATED WITH DECREASED OVERALL SURVIVAL IN PATIENTS WITH LUNG CANCER BRAIN METASTASES
por: Cialdella, Fia, et al.
Publicado: (2023)

The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma.
por: Fisken, J., et al.
Publicado: (1993)

HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases
por: Molina, Rafael, et al.
Publicado: (2011)

OTHR-10. THE NATIONAL DISTRIBUTION OF NEWLY-DIAGNOSED BRAIN METASTASES IN ADULTS VARIES WIDELY BY PATIENT DEMOGRAPHICS
por: Kavouridis, Vasileios, et al.
Publicado: (2019)

Elevated CA125 levels in patients with metastatic breast carcinoma.
por: Perey, L., et al.
Publicado: (1990)

73. PREDICTION OF A SECOND LOCAL RECURRENCE IN SURGICALLY TREATED RECURRENT BRAIN METASTASES PATIENTS
por: Tewarie, Ishaan, et al.
Publicado: (2020)

CA-125 is not a useful marker in metastatic breast cancer.
por: Seckl, M. J., et al.
Publicado: (1992)

CA 125 half-life in ovarian cancer: a multivariate survival analysis.
por: Yedema, C. A., et al.
Publicado: (1993)

Transactions of the American Gynæcological Society
por: Kynoch, J. A. C.
Publicado: (1903)

Progress in Gynæcology
por: Will, C. B.
Publicado: (1887)

Gynæcology in Bagdad
por: Sundberg, John C.
Publicado: (1894)

Gynæcology and Obstetrics
por: Swayne, Walter C.
Publicado: (1897)

Obstetrics and Gynæcology
por: Swayne, Walter C.
Publicado: (1903)

Obstetrics and Gynæcology
por: Swayne, Walter C.
Publicado: (1899)

Gynæcological Antiseptics
por: Dudley, E. C.
Publicado: (1887)

Visualization, navigation, augmentation. The ever-changing perspective of the neurosurgeon
por: Boaro, A., et al.
Publicado: (2022)

Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases
por: Mekenkamp, L J M, et al.
Publicado: (2010)

Simultaneous selection with fixed culling levels in the case of correlated traits
por: Ebl, A
Publicado: (1980)

Simultaneous selection with fixed culling levels in the case of correlated traits
por: Ebl, A
Publicado: (1980)

Some Gynæcological Laparotomies
por: Brodribb, C.
Publicado: (1916)

Fibrinolytics and Intraventricular Hemorrhage: A Systematic Review and Meta-analysis
por: van Solinge, Thomas S., et al.
Publicado: (2019)

Exploring the Glycosylation of Serum CA125
por: Saldova, Radka, et al.
Publicado: (2013)

SPCR-07 REDEFINING BOUNDARIES: STEREOTACTIC RADIOSURGERY FOR ENHANCED QUALITY OF LIFE AND SURVIVAL IN PATIENTS WITH 5-20 BRAIN METASTASES
por: Cialdella, Fia, et al.
Publicado: (2023)

Effect of radiation therapy on cerebral cortical thickness in glioma patients: Treatment-induced thinning of the healthy cortex
por: Nagtegaal, Steven H J, et al.
Publicado: (2020)

Dose-dependent volume loss in subcortical deep grey matter structures after cranial radiotherapy
por: Nagtegaal, Steven H.J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nlc3597r4uo5ohfa60gcjhs4vj